Stan Grof's Contributions to FDA Drug Development & Research with Psychedelics - Rick Doblin
1,591 views · Published 20 January 2015 · 31:12 · Indexed 6 November 2026
Channel: MAPS · 2015 · Nonprofits & Activism
MAPS Founder Rick Doblin, Ph.D., speaks about how Stanislav Grof's research influences MAPS' clinical studies focused on developing psychedelic-assisted psychotherapy into a prescription treatment. This talk was filmed during the Expanding and Reenchanting the Psyche: The Pioneering Thought of Stanislav Grof conference at the California Institute of Integral Studies (CIIS) on October 24, 2014. Filmed and edited by Chad Alexander Help us caption and translate this video on Amara: http://bit.ly/1yH54fi
More from this channel
-
0:45
MAPS - The Multidisciplinary Association for Psychedelic Studies 44 second PSA
-
5:07
Rick Doblin, Ph.D. Discusses MDMA at Arab/Israeli Joint Conference
-
4:00
NPR News: Ricaurte MDMA Research Paper Retraction
-
8:48
MAPS Member Video - Drug War Stories
-
13:18
Ibogaine Treatment - Clare Wilkins - Part 2 of 2
-
2:34
MAPS First Friday Art Tour - April 6, 2012
-
1:09
Rick Doblin: MDMA for PTSD
-
22:22
Thomas Kingsley Brown - Ibogaine-Assisted Treatment for Opiate Addiction